Overview

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Health care facility based, randomized, controlled, open label, superiority trial with 3 arms
Phase:
Phase 3
Details
Lead Sponsor:
Menzies School of Health Research
Collaborators:
Addis Ababa University
Ethiopian Public Health Institute
Mahidol Oxford Tropical Medicine Research Unit
National Centre for Parasitology, Entomology and Malaria Control, Cambodia
Universitas Sumatera Utara
University of Melbourne
Treatments:
Primaquine
Tafenoquine